“…Most modern authorities recommend that in these circumstances the neurolepüchaloperidol is the drug of choice, because of its relative freedom from cardiac, autonomie, and respiratory side-effects. Due to the risk of disabling extrapyramidal sideeffects and the relatively prolonged half-life in the elderly, titration up from a low starting dose is advised (Lipowski, 1989;Fairweather, 1990;Burns & Baldwin, 1994). The author's informal inquiries from Senior House Officers (SHOs) working in the Department of Health Care of the Elderly, Uni versity Hospital Nottingham, suggested that many junior doctors were unsure of what drug strategy to use in these circumstances and therefore an enquiry into current opinion among trainees seemed appropriate.…”